Last 12 months
Inside the activity.
0 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 09, 2021 Filed Jun 3, 2021 21:03 UTC |
ROCK ROBERT HDirector
|
GiftCommon Stock | 174 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-037746 · doc4.xml · nonDerivative · entry 1 ROCK ROBERT H · CIK 0001193199 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,326 Read SEC document |
| December 22, 2020 Filed Dec 31, 2020 21:24 UTC |
CALDWELL DONALD RDirector
|
GiftCommon Stock | 200 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-065682 · doc4.xml · nonDerivative · entry 1 CALDWELL DONALD R · CIK 0001211700 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,981 Read SEC document |
| November 18, 2020 Filed Nov 20, 2020 21:13 UTC |
Hall Mary DeanSVP, CFO and Treasurer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,445 | $0.00 Strike: $134.60 | $0.00 |
DisclosureSEC source: 0001209191-20-059636 · doc4.xml · derivative · entry 11 Hall Mary Dean · CIK 0001659705 · SVP, CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,445 shares Expires 2024-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: The options for this grant vested in three annual installments: 815 shares on February 27, 2018; 815 shares on February 27, 2019; and 815 shares on February 27, 2020. Read SEC document |
| November 18, 2020 Filed Nov 20, 2020 21:13 UTC |
Hall Mary DeanSVP, CFO and Treasurer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,838 | $0.00 Strike: $72.12 | $0.00 |
DisclosureSEC source: 0001209191-20-059636 · doc4.xml · derivative · entry 10 Hall Mary Dean · CIK 0001659705 · SVP, CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,838 shares Expires 2023-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The options for this grant vested in three annual installments: 1,280 shares on February 23, 2017; 1,279 shares on February 23, 2018; and 1,279 shares on February 23, 2019. Read SEC document |
| November 18, 2020 Filed Nov 20, 2020 21:13 UTC |
Hall Mary DeanSVP, CFO and Treasurer
|
SaleCommon Stock | 404 | $260.35 | $105,181.40 |
DisclosureSEC source: 0001209191-20-059636 · doc4.xml · nonDerivative · entry 8 Hall Mary Dean · CIK 0001659705 · SVP, CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,660 F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $260.03 to $260.76, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (6) to this Form 4. Read SEC document |
| November 18, 2020 Filed Nov 20, 2020 21:13 UTC |
Hall Mary DeanSVP, CFO and Treasurer
|
SaleCommon Stock | 387 | $259.25 | $100,329.75 |
DisclosureSEC source: 0001209191-20-059636 · doc4.xml · nonDerivative · entry 7 Hall Mary Dean · CIK 0001659705 · SVP, CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,064 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $259.00 to $259.93, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (5) to this Form 4. Read SEC document |
| November 18, 2020 Filed Nov 20, 2020 21:13 UTC |
Hall Mary DeanSVP, CFO and Treasurer
|
SaleCommon Stock | 1,400 | $258.57 | $361,998.00 |
DisclosureSEC source: 0001209191-20-059636 · doc4.xml · nonDerivative · entry 6 Hall Mary Dean · CIK 0001659705 · SVP, CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,451 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $258.00 to $258.83, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) to this Form 4. Read SEC document |
| November 18, 2020 Filed Nov 20, 2020 21:13 UTC |
Hall Mary DeanSVP, CFO and Treasurer
|
SaleCommon Stock | 400 | $255.70 | $102,280.00 |
DisclosureSEC source: 0001209191-20-059636 · doc4.xml · nonDerivative · entry 5 Hall Mary Dean · CIK 0001659705 · SVP, CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,851 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $255.47 to $256.04, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4. Read SEC document |
| November 18, 2020 Filed Nov 20, 2020 21:13 UTC |
Hall Mary DeanSVP, CFO and Treasurer
|
SaleCommon Stock | 2,167 | $255.05 | $552,693.35 |
DisclosureSEC source: 0001209191-20-059636 · doc4.xml · nonDerivative · entry 4 Hall Mary Dean · CIK 0001659705 · SVP, CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,251 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $254.46 to $255.343, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| November 18, 2020 Filed Nov 20, 2020 21:13 UTC |
Hall Mary DeanSVP, CFO and Treasurer
|
Exercise / conversionCommon Stock | 2,445 | $134.60 | $329,097.00 |
DisclosureSEC source: 0001209191-20-059636 · doc4.xml · nonDerivative · entry 3 Hall Mary Dean · CIK 0001659705 · SVP, CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,418 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 18, 2020 Filed Nov 20, 2020 21:13 UTC |
Hall Mary DeanSVP, CFO and Treasurer
|
SaleCommon Stock | 3,873 | $253.73 | $982,696.29 |
DisclosureSEC source: 0001209191-20-059636 · doc4.xml · nonDerivative · entry 2 Hall Mary Dean · CIK 0001659705 · SVP, CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,973 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $253.45 to $254.43, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| November 18, 2020 Filed Nov 20, 2020 21:13 UTC |
Hall Mary DeanSVP, CFO and Treasurer
|
Exercise / conversionCommon Stock | 3,838 | $72.12 | $276,796.56 |
DisclosureSEC source: 0001209191-20-059636 · doc4.xml · nonDerivative · entry 1 Hall Mary Dean · CIK 0001659705 · SVP, CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,846 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 21:31 UTC |
Traub Robert TSVP, GC & Corp. Sec.
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 645 | $0.00 Strike: $154.92 | $0.00 |
DisclosureSEC source: 0001209191-20-059106 · doc4.xml · derivative · entry 10 Traub Robert T · CIK 0001783973 · SVP, GC & Corp. Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,565 Underlying: Common Stock · 645 shares Expires 2026-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The options for this grant vest in three annual installments: 737 shares on February 25, 2020; 737 shares on February 25, 2021; and 736 shares on February 25, 2022. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 21:31 UTC |
Traub Robert TSVP, GC & Corp. Sec.
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,444 | $0.00 Strike: $151.75 | $0.00 |
DisclosureSEC source: 0001209191-20-059106 · doc4.xml · derivative · entry 9 Traub Robert T · CIK 0001783973 · SVP, GC & Corp. Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 721 Underlying: Common Stock · 1,444 shares Expires 2025-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The options for this grant vest in three annual installments: 722 shares on February 26, 2019; 722 shares on February 26, 2020; and 721 shares on February 26, 2021. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 21:31 UTC |
Traub Robert TSVP, GC & Corp. Sec.
|
SaleCommon Stock | 100 | $255.28 | $25,528.00 |
DisclosureSEC source: 0001209191-20-059106 · doc4.xml · nonDerivative · entry 7 Traub Robert T · CIK 0001783973 · SVP, GC & Corp. Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,870 Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 21:31 UTC |
Traub Robert TSVP, GC & Corp. Sec.
|
SaleCommon Stock | 400 | $254.20 | $101,680.00 |
DisclosureSEC source: 0001209191-20-059106 · doc4.xml · nonDerivative · entry 6 Traub Robert T · CIK 0001783973 · SVP, GC & Corp. Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,970 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $253.80 to $254.52, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 21:31 UTC |
Traub Robert TSVP, GC & Corp. Sec.
|
SaleCommon Stock | 145 | $252.94 | $36,676.30 |
DisclosureSEC source: 0001209191-20-059106 · doc4.xml · nonDerivative · entry 5 Traub Robert T · CIK 0001783973 · SVP, GC & Corp. Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,370 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $252.53 to $253.39, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 21:31 UTC |
Traub Robert TSVP, GC & Corp. Sec.
|
Exercise / conversionCommon Stock | 645 | $154.92 | $99,923.40 |
DisclosureSEC source: 0001209191-20-059106 · doc4.xml · nonDerivative · entry 4 Traub Robert T · CIK 0001783973 · SVP, GC & Corp. Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,515 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 21:31 UTC |
Traub Robert TSVP, GC & Corp. Sec.
|
SaleCommon Stock | 844 | $252.94 | $213,481.36 |
DisclosureSEC source: 0001209191-20-059106 · doc4.xml · nonDerivative · entry 3 Traub Robert T · CIK 0001783973 · SVP, GC & Corp. Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,870 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $252.53 to $253.39, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 21:31 UTC |
Traub Robert TSVP, GC & Corp. Sec.
|
SaleCommon Stock | 600 | $251.62 | $150,972.00 |
DisclosureSEC source: 0001209191-20-059106 · doc4.xml · nonDerivative · entry 2 Traub Robert T · CIK 0001783973 · SVP, GC & Corp. Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,714 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $251.13 to $251.92, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 21:31 UTC |
Traub Robert TSVP, GC & Corp. Sec.
|
Exercise / conversionCommon Stock | 1,444 | $151.75 | $219,127.00 |
DisclosureSEC source: 0001209191-20-059106 · doc4.xml · nonDerivative · entry 1 Traub Robert T · CIK 0001783973 · SVP, GC & Corp. Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,314 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 21:24 UTC |
PLATZER L WILBERTSVP, Global Ops, EHS & Prcmt
|
SaleCommon Stock | 500 | $252.95 | $126,475.00 |
DisclosureSEC source: 0001209191-20-059094 · doc4.xml · nonDerivative · entry 1 PLATZER L WILBERT · CIK 0001242086 · SVP, Global Ops, EHS & Prcmt 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,491 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $252.85 to $253.02, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 21:28 UTC |
STEEPLES ADRIANSVP, Managing Director - EMEA
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,228 | $0.00 Strike: $151.75 | $0.00 |
DisclosureSEC source: 0001209191-20-059097 · doc4.xml · derivative · entry 9 STEEPLES ADRIAN · CIK 0001580051 · SVP, Managing Director - EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 613 Underlying: Common Stock · 1,228 shares Expires 2025-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The options for this grant vest in three annual installments: 614 shares on February 26, 2019; 614 shares on February 26, 2020; and 613 shares on February 26, 2021. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 21:28 UTC |
STEEPLES ADRIANSVP, Managing Director - EMEA
|
SaleCommon Stock | 27 | $258.94 | $6,991.38 |
DisclosureSEC source: 0001209191-20-059097 · doc4.xml · nonDerivative · entry 8 STEEPLES ADRIAN · CIK 0001580051 · SVP, Managing Director - EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,475 Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 21:28 UTC |
STEEPLES ADRIANSVP, Managing Director - EMEA
|
SaleCommon Stock | 368 | $257.65 | $94,815.20 |
DisclosureSEC source: 0001209191-20-059097 · doc4.xml · nonDerivative · entry 7 STEEPLES ADRIAN · CIK 0001580051 · SVP, Managing Director - EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,502 F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $257.26 to $258.22, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (6) to this Form 4. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 21:28 UTC |
STEEPLES ADRIANSVP, Managing Director - EMEA
|
SaleCommon Stock | 282 | $256.70 | $72,389.40 |
DisclosureSEC source: 0001209191-20-059097 · doc4.xml · nonDerivative · entry 6 STEEPLES ADRIAN · CIK 0001580051 · SVP, Managing Director - EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,870 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $256.20 to $257.14, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (5) to this Form 4. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 21:28 UTC |
STEEPLES ADRIANSVP, Managing Director - EMEA
|
SaleCommon Stock | 240 | $255.53 | $61,327.20 |
DisclosureSEC source: 0001209191-20-059097 · doc4.xml · nonDerivative · entry 5 STEEPLES ADRIAN · CIK 0001580051 · SVP, Managing Director - EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,152 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $255.13 to $255.99, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) to this Form 4. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 21:28 UTC |
STEEPLES ADRIANSVP, Managing Director - EMEA
|
SaleCommon Stock | 76 | $254.14 | $19,314.64 |
DisclosureSEC source: 0001209191-20-059097 · doc4.xml · nonDerivative · entry 4 STEEPLES ADRIAN · CIK 0001580051 · SVP, Managing Director - EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,392 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $253.72 to $254.96, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 21:28 UTC |
STEEPLES ADRIANSVP, Managing Director - EMEA
|
SaleCommon Stock | 144 | $253.08 | $36,443.52 |
DisclosureSEC source: 0001209191-20-059097 · doc4.xml · nonDerivative · entry 3 STEEPLES ADRIAN · CIK 0001580051 · SVP, Managing Director - EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,468 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $252.58 to $253.47, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 21:28 UTC |
STEEPLES ADRIANSVP, Managing Director - EMEA
|
SaleCommon Stock | 91 | $251.83 | $22,916.53 |
DisclosureSEC source: 0001209191-20-059097 · doc4.xml · nonDerivative · entry 2 STEEPLES ADRIAN · CIK 0001580051 · SVP, Managing Director - EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,612 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $251.44 to $252.03, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 21:28 UTC |
STEEPLES ADRIANSVP, Managing Director - EMEA
|
Exercise / conversionCommon Stock | 1,228 | $151.75 | $186,349.00 |
DisclosureSEC source: 0001209191-20-059097 · doc4.xml · nonDerivative · entry 1 STEEPLES ADRIAN · CIK 0001580051 · SVP, Managing Director - EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,703 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 16, 2020 Filed Dec 31, 2020 21:17 UTC |
BARRY MICHAEL FDirector · Chairman, CEO and President
|
GiftCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-065675 · doc4.xml · nonDerivative · entry 1 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,778 Read SEC document |
| November 12, 2020 Filed Nov 16, 2020 21:21 UTC |
BERQUIST JOSEPH ASVP, GL SPEC BUS & CSO
|
OtherCommon Stock | 1,400 | $239.77 | $335,678.00 |
DisclosureSEC source: 0001209191-20-058466 · doc4.xml · nonDerivative · entry 1 BERQUIST JOSEPH A · CIK 0001487224 · SVP, GL SPEC BUS & CSO 10b5-1 filing: Not disclosed Ownership: Indirect · By 401(k) Disclosed balance after: 201 F1 · balance_after: Based on account information as of November 12, 2020 and obtained by reporting person from Plan Administrator. Read SEC document |
| November 12, 2020 Filed Dec 31, 2020 21:12 UTC |
ROCK ROBERT HDirector
|
GiftCommon Stock | 101 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-065669 · doc4.xml · nonDerivative · entry 2 ROCK ROBERT H · CIK 0001193199 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Read SEC document |
| November 11, 2020 Filed Dec 31, 2020 21:12 UTC |
ROCK ROBERT HDirector
|
GiftCommon Stock | 515 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-065669 · doc4.xml · nonDerivative · entry 1 ROCK ROBERT H · CIK 0001193199 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,601 Read SEC document |
| November 10, 2020 Filed Dec 31, 2020 21:21 UTC |
FRISBY JEFFRY DDirector
|
GiftCommon Stock | 80 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-065679 · doc4.xml · nonDerivative · entry 1 FRISBY JEFFRY D · CIK 0001061274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,650 Read SEC document |
| November 05, 2020 Filed Nov 5, 2020 21:22 UTC |
HOSTETTER SHANEVP, Finance and CAO
|
SaleCommon Stock | 75 | $203.00 | $15,225.00 |
DisclosureSEC source: 0001209191-20-057136 · doc4.xml · nonDerivative · entry 3 HOSTETTER SHANE · CIK 0001576686 · VP, Finance and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,587 F1 · kind: The sale of shares reported for this transaction was effected pursuant to a Rule 10b5-1 Plan entered into by reporting person on August 28, 2020. Read SEC document |
| November 03, 2020 Filed Nov 5, 2020 21:22 UTC |
HOSTETTER SHANEVP, Finance and CAO
|
SaleCommon Stock | 33 | $204.38 | $6,744.54 |
DisclosureSEC source: 0001209191-20-057136 · doc4.xml · nonDerivative · entry 2 HOSTETTER SHANE · CIK 0001576686 · VP, Finance and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,662 F1 · kind: The sale of shares reported for this transaction was effected pursuant to a Rule 10b5-1 Plan entered into by reporting person on August 28, 2020. Read SEC document |
| November 03, 2020 Filed Nov 5, 2020 21:22 UTC |
HOSTETTER SHANEVP, Finance and CAO
|
SaleCommon Stock | 743 | $203.10 | $150,903.30 |
DisclosureSEC source: 0001209191-20-057136 · doc4.xml · nonDerivative · entry 1 HOSTETTER SHANE · CIK 0001576686 · VP, Finance and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,695 F1 · kind: The sale of shares reported for this transaction was effected pursuant to a Rule 10b5-1 Plan entered into by reporting person on August 28, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $203.00 to $203.70, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| October 12, 2020 Filed Oct 13, 2020 20:22 UTC |
BARRY MICHAEL FDirector · Chairman, CEO and President
|
SaleCommon Stock | 2,884 | $195.65 | $564,254.60 |
DisclosureSEC source: 0001209191-20-054635 · doc4.xml · nonDerivative · entry 9 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,778 F1 · kind: The sale of shares reported for this transaction was effected pursuant to a Rule 10b5-1 Plan entered into by reporting person on August 28, 2020. There will be no further sales under this Plan. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $195.26 to $196.23, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (6) to this Form 4. Read SEC document |
| October 12, 2020 Filed Oct 13, 2020 20:22 UTC |
BARRY MICHAEL FDirector · Chairman, CEO and President
|
SaleCommon Stock | 1,500 | $194.99 | $292,485.00 |
DisclosureSEC source: 0001209191-20-054635 · doc4.xml · nonDerivative · entry 8 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,662 F1 · kind: The sale of shares reported for this transaction was effected pursuant to a Rule 10b5-1 Plan entered into by reporting person on August 28, 2020. There will be no further sales under this Plan. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $194.25 to $195.24, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (5) to this Form 4. Read SEC document |
| October 12, 2020 Filed Oct 13, 2020 20:22 UTC |
BARRY MICHAEL FDirector · Chairman, CEO and President
|
SaleCommon Stock | 100 | $193.24 | $19,324.00 |
DisclosureSEC source: 0001209191-20-054635 · doc4.xml · nonDerivative · entry 7 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,162 F1 · kind: The sale of shares reported for this transaction was effected pursuant to a Rule 10b5-1 Plan entered into by reporting person on August 28, 2020. There will be no further sales under this Plan. Read SEC document |
| October 12, 2020 Filed Oct 13, 2020 20:22 UTC |
BARRY MICHAEL FDirector · Chairman, CEO and President
|
SaleCommon Stock | 100 | $193.14 | $19,313.50 |
DisclosureSEC source: 0001209191-20-054635 · doc4.xml · nonDerivative · entry 6 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,262 F1 · kind: The sale of shares reported for this transaction was effected pursuant to a Rule 10b5-1 Plan entered into by reporting person on August 28, 2020. There will be no further sales under this Plan. Read SEC document |
| October 09, 2020 Filed Oct 13, 2020 20:22 UTC |
BARRY MICHAEL FDirector · Chairman, CEO and President
|
SaleCommon Stock | 82 | $196.72 | $16,131.04 |
DisclosureSEC source: 0001209191-20-054635 · doc4.xml · nonDerivative · entry 5 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,362 F1 · kind: The sale of shares reported for this transaction was effected pursuant to a Rule 10b5-1 Plan entered into by reporting person on August 28, 2020. There will be no further sales under this Plan. Read SEC document |
| October 09, 2020 Filed Oct 13, 2020 20:22 UTC |
BARRY MICHAEL FDirector · Chairman, CEO and President
|
SaleCommon Stock | 1,734 | $195.78 | $339,482.52 |
DisclosureSEC source: 0001209191-20-054635 · doc4.xml · nonDerivative · entry 4 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,444 F1 · kind: The sale of shares reported for this transaction was effected pursuant to a Rule 10b5-1 Plan entered into by reporting person on August 28, 2020. There will be no further sales under this Plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $195.56 to $196.305, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) to this Form 4. Read SEC document |
| October 09, 2020 Filed Oct 13, 2020 20:22 UTC |
BARRY MICHAEL FDirector · Chairman, CEO and President
|
SaleCommon Stock | 3,700 | $195.11 | $721,907.00 |
DisclosureSEC source: 0001209191-20-054635 · doc4.xml · nonDerivative · entry 3 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,178 F1 · kind: The sale of shares reported for this transaction was effected pursuant to a Rule 10b5-1 Plan entered into by reporting person on August 28, 2020. There will be no further sales under this Plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $194.53 to $195.52, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4. Read SEC document |
| October 09, 2020 Filed Oct 13, 2020 20:22 UTC |
BARRY MICHAEL FDirector · Chairman, CEO and President
|
SaleCommon Stock | 4,900 | $194.06 | $950,884.69 |
DisclosureSEC source: 0001209191-20-054635 · doc4.xml · nonDerivative · entry 2 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,878 F1 · kind: The sale of shares reported for this transaction was effected pursuant to a Rule 10b5-1 Plan entered into by reporting person on August 28, 2020. There will be no further sales under this Plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $193.455 to $194.455, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| August 27, 2020 Filed Aug 31, 2020 21:16 UTC | OtherPrepaid Variable Forward Sale Contract · Derivative | 60,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-20-100861 · tm2029863d3_4.xml · derivative · entry 4 Gulf Hungary Holding Korlatolt Felelossegu Tarsasag · CIK 0001783455 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By QH Hungary Holdings Limited Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires not disclosed F3 · derivative.exercise_price: On August 27, 2020, QH Hungary entered into a prepaid variable share forward transaction with Citibank, N.A. ("Citibank"). See Footnote 4 and Remarks for details of the transaction. F4 · derivative.exercise_price: The prepaid forward transactions with JPMorgan and Citibank are each divided into 14 components (each a "Component"). For each Component, QH Hungary is obligated to, on the settlement date (the "Settlement Date") determined based on the specified scheduled valuation date within the period from August 18, 2022 to September 7, 2022, either, at QH Hungary's option, (i) up to 10,000 Shares to JPMorgan and up to 4,286 Shares (or 4,282 Shares for the last Settlement Date) to Citi (such Share number, "Subject Number") based on the average market price of the Shares determined as described below in Remarks or (ii) an amount of cash equivalent to the value of such Shares. In exchange for assuming the obligation under each contract, QH Hungary received an upfront cash prepayment of $9,481,130.00 and $22,122,636.00 from Citibank and JPMorgan, respectively. F3 · kind: On August 27, 2020, QH Hungary entered into a prepaid variable share forward transaction with Citibank, N.A. ("Citibank"). See Footnote 4 and Remarks for details of the transaction. F4 · kind: The prepaid forward transactions with JPMorgan and Citibank are each divided into 14 components (each a "Component"). For each Component, QH Hungary is obligated to, on the settlement date (the "Settlement Date") determined based on the specified scheduled valuation date within the period from August 18, 2022 to September 7, 2022, either, at QH Hungary's option, (i) up to 10,000 Shares to JPMorgan and up to 4,286 Shares (or 4,282 Shares for the last Settlement Date) to Citi (such Share number, "Subject Number") based on the average market price of the Shares determined as described below in Remarks or (ii) an amount of cash equivalent to the value of such Shares. In exchange for assuming the obligation under each contract, QH Hungary received an upfront cash prepayment of $9,481,130.00 and $22,122,636.00 from Citibank and JPMorgan, respectively. F3 · price: On August 27, 2020, QH Hungary entered into a prepaid variable share forward transaction with Citibank, N.A. ("Citibank"). See Footnote 4 and Remarks for details of the transaction. F4 · price: The prepaid forward transactions with JPMorgan and Citibank are each divided into 14 components (each a "Component"). For each Component, QH Hungary is obligated to, on the settlement date (the "Settlement Date") determined based on the specified scheduled valuation date within the period from August 18, 2022 to September 7, 2022, either, at QH Hungary's option, (i) up to 10,000 Shares to JPMorgan and up to 4,286 Shares (or 4,282 Shares for the last Settlement Date) to Citi (such Share number, "Subject Number") based on the average market price of the Shares determined as described below in Remarks or (ii) an amount of cash equivalent to the value of such Shares. In exchange for assuming the obligation under each contract, QH Hungary received an upfront cash prepayment of $9,481,130.00 and $22,122,636.00 from Citibank and JPMorgan, respectively. F3 · derivative.exercise_date: On August 27, 2020, QH Hungary entered into a prepaid variable share forward transaction with Citibank, N.A. ("Citibank"). See Footnote 4 and Remarks for details of the transaction. F4 · derivative.exercise_date: The prepaid forward transactions with JPMorgan and Citibank are each divided into 14 components (each a "Component"). For each Component, QH Hungary is obligated to, on the settlement date (the "Settlement Date") determined based on the specified scheduled valuation date within the period from August 18, 2022 to September 7, 2022, either, at QH Hungary's option, (i) up to 10,000 Shares to JPMorgan and up to 4,286 Shares (or 4,282 Shares for the last Settlement Date) to Citi (such Share number, "Subject Number") based on the average market price of the Shares determined as described below in Remarks or (ii) an amount of cash equivalent to the value of such Shares. In exchange for assuming the obligation under each contract, QH Hungary received an upfront cash prepayment of $9,481,130.00 and $22,122,636.00 from Citibank and JPMorgan, respectively. F3 · derivative.expiration_date: On August 27, 2020, QH Hungary entered into a prepaid variable share forward transaction with Citibank, N.A. ("Citibank"). See Footnote 4 and Remarks for details of the transaction. F4 · derivative.expiration_date: The prepaid forward transactions with JPMorgan and Citibank are each divided into 14 components (each a "Component"). For each Component, QH Hungary is obligated to, on the settlement date (the "Settlement Date") determined based on the specified scheduled valuation date within the period from August 18, 2022 to September 7, 2022, either, at QH Hungary's option, (i) up to 10,000 Shares to JPMorgan and up to 4,286 Shares (or 4,282 Shares for the last Settlement Date) to Citi (such Share number, "Subject Number") based on the average market price of the Shares determined as described below in Remarks or (ii) an amount of cash equivalent to the value of such Shares. In exchange for assuming the obligation under each contract, QH Hungary received an upfront cash prepayment of $9,481,130.00 and $22,122,636.00 from Citibank and JPMorgan, respectively. Read SEC document |
|
| August 27, 2020 Filed Aug 31, 2020 21:16 UTC | OtherPrepaid Variable Forward Sale Contract · Derivative | 140,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-20-100861 · tm2029863d3_4.xml · derivative · entry 3 Gulf Hungary Holding Korlatolt Felelossegu Tarsasag · CIK 0001783455 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By QH Hungary Holdings Limited Disclosed balance after: 140,000 Underlying: Common Stock · 140,000 shares Expires not disclosed F2 · derivative.exercise_price: On August 27, 2020, QH Hungary entered into a prepaid variable share forward transaction with JPMorgan Chase Bank, National Association ("JPMorgan"). See Footnote 4 and Remarks for details of the transaction. F4 · derivative.exercise_price: The prepaid forward transactions with JPMorgan and Citibank are each divided into 14 components (each a "Component"). For each Component, QH Hungary is obligated to, on the settlement date (the "Settlement Date") determined based on the specified scheduled valuation date within the period from August 18, 2022 to September 7, 2022, either, at QH Hungary's option, (i) up to 10,000 Shares to JPMorgan and up to 4,286 Shares (or 4,282 Shares for the last Settlement Date) to Citi (such Share number, "Subject Number") based on the average market price of the Shares determined as described below in Remarks or (ii) an amount of cash equivalent to the value of such Shares. In exchange for assuming the obligation under each contract, QH Hungary received an upfront cash prepayment of $9,481,130.00 and $22,122,636.00 from Citibank and JPMorgan, respectively. F2 · kind: On August 27, 2020, QH Hungary entered into a prepaid variable share forward transaction with JPMorgan Chase Bank, National Association ("JPMorgan"). See Footnote 4 and Remarks for details of the transaction. F4 · kind: The prepaid forward transactions with JPMorgan and Citibank are each divided into 14 components (each a "Component"). For each Component, QH Hungary is obligated to, on the settlement date (the "Settlement Date") determined based on the specified scheduled valuation date within the period from August 18, 2022 to September 7, 2022, either, at QH Hungary's option, (i) up to 10,000 Shares to JPMorgan and up to 4,286 Shares (or 4,282 Shares for the last Settlement Date) to Citi (such Share number, "Subject Number") based on the average market price of the Shares determined as described below in Remarks or (ii) an amount of cash equivalent to the value of such Shares. In exchange for assuming the obligation under each contract, QH Hungary received an upfront cash prepayment of $9,481,130.00 and $22,122,636.00 from Citibank and JPMorgan, respectively. F2 · price: On August 27, 2020, QH Hungary entered into a prepaid variable share forward transaction with JPMorgan Chase Bank, National Association ("JPMorgan"). See Footnote 4 and Remarks for details of the transaction. F4 · price: The prepaid forward transactions with JPMorgan and Citibank are each divided into 14 components (each a "Component"). For each Component, QH Hungary is obligated to, on the settlement date (the "Settlement Date") determined based on the specified scheduled valuation date within the period from August 18, 2022 to September 7, 2022, either, at QH Hungary's option, (i) up to 10,000 Shares to JPMorgan and up to 4,286 Shares (or 4,282 Shares for the last Settlement Date) to Citi (such Share number, "Subject Number") based on the average market price of the Shares determined as described below in Remarks or (ii) an amount of cash equivalent to the value of such Shares. In exchange for assuming the obligation under each contract, QH Hungary received an upfront cash prepayment of $9,481,130.00 and $22,122,636.00 from Citibank and JPMorgan, respectively. F2 · derivative.exercise_date: On August 27, 2020, QH Hungary entered into a prepaid variable share forward transaction with JPMorgan Chase Bank, National Association ("JPMorgan"). See Footnote 4 and Remarks for details of the transaction. F4 · derivative.exercise_date: The prepaid forward transactions with JPMorgan and Citibank are each divided into 14 components (each a "Component"). For each Component, QH Hungary is obligated to, on the settlement date (the "Settlement Date") determined based on the specified scheduled valuation date within the period from August 18, 2022 to September 7, 2022, either, at QH Hungary's option, (i) up to 10,000 Shares to JPMorgan and up to 4,286 Shares (or 4,282 Shares for the last Settlement Date) to Citi (such Share number, "Subject Number") based on the average market price of the Shares determined as described below in Remarks or (ii) an amount of cash equivalent to the value of such Shares. In exchange for assuming the obligation under each contract, QH Hungary received an upfront cash prepayment of $9,481,130.00 and $22,122,636.00 from Citibank and JPMorgan, respectively. F2 · derivative.expiration_date: On August 27, 2020, QH Hungary entered into a prepaid variable share forward transaction with JPMorgan Chase Bank, National Association ("JPMorgan"). See Footnote 4 and Remarks for details of the transaction. F4 · derivative.expiration_date: The prepaid forward transactions with JPMorgan and Citibank are each divided into 14 components (each a "Component"). For each Component, QH Hungary is obligated to, on the settlement date (the "Settlement Date") determined based on the specified scheduled valuation date within the period from August 18, 2022 to September 7, 2022, either, at QH Hungary's option, (i) up to 10,000 Shares to JPMorgan and up to 4,286 Shares (or 4,282 Shares for the last Settlement Date) to Citi (such Share number, "Subject Number") based on the average market price of the Shares determined as described below in Remarks or (ii) an amount of cash equivalent to the value of such Shares. In exchange for assuming the obligation under each contract, QH Hungary received an upfront cash prepayment of $9,481,130.00 and $22,122,636.00 from Citibank and JPMorgan, respectively. Read SEC document |
|
| August 27, 2020 Filed Aug 31, 2020 21:16 UTC | PurchaseCommon Stock | 150,131 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-20-100861 · tm2029863d3_4.xml · nonDerivative · entry 2 Gulf Hungary Holding Korlatolt Felelossegu Tarsasag · CIK 0001783455 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By QH Hungary Holdings Limited Disclosed balance after: 4,054,584 F1 · kind: Transfer by the reporting person to QH Hungary Holdings Limited, a wholly owned subsidiary of the reporting person ("QH Hungary"). F1 · price: Transfer by the reporting person to QH Hungary Holdings Limited, a wholly owned subsidiary of the reporting person ("QH Hungary"). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.